Trent G. Kamke - 08 Jan 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Senior V. P., Operations
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
08 Jan 2026
Net transactions value
+$100,018
Form type
4
Filing time
12 Jan 2026, 17:16:50 UTC
Previous filing
15 Dec 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kamke Trent G Senior V. P., Operations C/O LEMAITRE VASCULAR , INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 12 Jan 2025 0001365739

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $45,829 +1,229 +28% $37.29 5,646 08 Jan 2026 Direct F1
transaction LMAT Common Stock Options Exercise $54,189 +1,115 +20% $48.60 6,761 08 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,229 -25% $0.000000 3,690 08 Jan 2026 Common Stock 1,229 $37.29 Direct F2
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,115 -18% $0.000000 5,085 08 Jan 2026 Common Stock 1,115 $48.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This option is fully vested and exercisable.